Lab
Laboratory Corporation of America
Laboratory Corporation of America was paid $436K by Medicaid between Feb 2018 and Dec 2024, across 79 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 10% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA
WAUKESHA, WI 53188
WAUKESHA, WI 53188
33aNPI1831619535assigned 06/23/2017
33bProvider typeClinical Medical Laboratory
28Total paid$436K
24GClaims44,208
24DCodes billed79
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Wisconsin
Rank by total paid#28 of 75
Median peer was paid$106K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,623 | $6K | |
| 2019 | 1,744 | $5K | |
| 2020 | 1,113 | $3K | |
| 2021 | 838 | $2K | |
| 2022 | 1,424 | $5K | |
| 2023 | 9,715 | $100K | |
| 2024incomplete | 27,751 | $315K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10% | 1,811 | 1,723 | $46K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10% | 1,813 | 1,724 | $45K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 7.8% | 1,321 | 1,262 | $34K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7.1% | 1,414 | 1,362 | $31K |
| 80061 | Lipid panel | 5.9% | 3,331 | 3,126 | $26K |
| 80053 | Comprehensive metabolic panel | 5.5% | 3,782 | 3,429 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.3% | 738 | 688 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.3% | 1,056 | 1,024 | $19K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.1% | 230 | 207 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.8% | 1,766 | 1,703 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.7% | 2,238 | 2,118 | $12K |
| 80050 | General health panel | 2.7% | 356 | 341 | $12K |
67 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.5% | 670 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 2,377 | $10K |
| 85027 | 1.9% | 2,269 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 1,547 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 215 | $7K |
| 86803 | 1.4% | 668 | $6K | |
| 82728 | 1.3% | 710 | $6K | |
| 87631 | 1.3% | 93 | $6K | |
| 82247 | 1.3% | 1,798 | $6K | |
| 82607 | 1.2% | 508 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 892 | $5K |
| 82248 | 1.1% | 1,532 | $5K | |
| 86780 | <1% | 561 | $4K | |
| 80306 | <1% | 587 | $4K | |
| 84702 | <1% | 459 | $4K | |
| 87081 | <1% | 666 | $3K | |
| 83550 | <1% | 433 | $2K | |
| 84439 | <1% | 414 | $2K | |
| 87070 | <1% | 363 | $2K | |
| 84153 | <1% | 178 | $2K | |
| 87210 | <1% | 657 | $2K | |
| 82746 | <1% | 200 | $2K | |
| 83540 | <1% | 501 | $2K | |
| 82570 | <1% | 593 | $2K | |
| 87340 | <1% | 247 | $2K | |
| 82043 | <1% | 449 | $2K | |
| 82950 | <1% | 455 | $1K | |
| 86140 | <1% | 295 | $997.42 | |
| 83001 | <1% | 84 | $963.20 | |
| 84146 | <1% | 58 | $782.06 | |
| 85018 | <1% | 428 | $746.35 | |
| 86762 | <1% | 77 | $735.90 | |
| 84481 | <1% | 64 | $713.72 | |
| 86850 | <1% | 146 | $695.01 | |
| 87563 | <1% | 27 | $659.48 | |
| 86706 | <1% | 83 | $632.37 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $605.83 |
| 84403 | <1% | 40 | $575.88 | |
| 83735 | <1% | 129 | $566.29 | |
| 80076 | <1% | 87 | $500.16 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 21 | $457.77 |
| 83970 | <1% | 14 | $449.78 | |
| 86160 | <1% | 25 | $419.84 | |
| 84460 | <1% | 118 | $415.56 | |
| 82670 | <1% | 20 | $378.57 | |
| 84550 | <1% | 126 | $369.87 | |
| 86787 | <1% | 61 | $338.36 | |
| 84450 | <1% | 95 | $323.26 | |
| 85652 | <1% | 175 | $289.84 | |
| 81015 | <1% | 151 | $284.10 | |
| 81001 | <1% | 161 | $269.47 | |
| 82565 | <1% | 81 | $264.75 | |
| 85610 | <1% | 92 | $230.48 | |
| 86704 | <1% | 27 | $225.99 | |
| 82947 | <1% | 84 | $224.39 | |
| 80074 | <1% | 16 | $202.22 | |
| 86431 | <1% | 39 | $154.19 | |
| 86900 | <1% | 90 | $136.95 | |
| 86901 | <1% | 90 | $133.00 | |
| 84156 | <1% | 55 | $127.57 | |
| 87077 | <1% | 25 | $123.10 | |
| 87328 | <1% | 12 | $122.55 | |
| 87329 | <1% | 13 | $119.54 | |
| 85007 | <1% | 61 | $118.56 | |
| 83690 | <1% | 26 | $117.51 | |
| 36416 | <1% | 80 | $35.45 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,021 | $2.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.